Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor‐induced colitis

Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor‐induced colitis—authors' reply

Published:2022-12-05 Issue:1 Volume:57 Page:152-153
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Dahl Emilie K.¹^ORCID,Abed Osama K.²,Kjeldsen Jens²,Donia Marco³,Svane Inge M.³,Dige Anders⁴,Agnholt Jørgen S.⁴,Bjerrum Jacob T.¹,Seidelin Jakob B.¹

Affiliation:

1. Department of Gastroenterology Copenhagen University Hospital Herlev Denmark

2. Department of Gatroenterology, Odense University Hospital, and Research Unit of Medical Gastroenterology, Department of Clinical Research University of Southern Denmark Odense Denmark

3. Department of Onchology Copenhagen University Hospital Herlev Denmark

4. Department of Hepatology and Gastroenterology Aarhus university Hospital Aarhus Denmark

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17250

Reference6 articles.

1. Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor induced colitis;Hanauer S;Aliment Pharmacol Ther,2022

2. Safety and efficacy of infliximab and corticosteroid therapy in checkpoint inhibitor‐induced colitis

3. Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses

4. High Mortality Rate in Oral Glucocorticoid Users: A Population-Based Matched Cohort Study

5. Use of Glucocorticoids and Risk of Venous Thromboembolism

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Corticosteroid-resistant immune-related adverse events: a systematic review;Journal for ImmunoTherapy of Cancer;2024-01

2. Severe Immune-Mediated Colitis Induced by Checkpoint Inhibitors in an Adolescent With Lynch Syndrome;Cureus;2023-08-09